• 首页期刊简介编委会刊物订阅专栏专刊电子刊广告合作联系我们English
引用本文:刘先保,张春芳,詹鸿.右美托咪定器官保护作用研究进展[J].中国现代应用药学,2013,30(10):1148-1151.
LIU Xianbao,ZHANG Chunfang,ZHAN Hong.Research Progress of Dexmedetomidine in Organ Protection[J].Chin J Mod Appl Pharm(中国现代应用药学),2013,30(10):1148-1151.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2007次   下载 1241 本文二维码信息
码上扫一扫!
分享到: 微信 更多
右美托咪定器官保护作用研究进展
刘先保, 张春芳, 詹鸿
广州医科大学附属第三医院麻醉科,广州 510150
摘要:
右美托咪定是一种新型高选择性α2肾上腺素能受体激动剂,广泛应用于重症医学科镇静,也广泛应用于围术期镇静、镇痛,其在炎症抑制、免疫调节、器官保护作用方面也显示出明显的优势。本文就右美托咪定近几年的文献,对其器官保护作用方面进行综述。
关键词:  右美托咪定  器官保护
DOI:
分类号:
基金项目:广东省科技厅项目(2012B020700007)
Research Progress of Dexmedetomidine in Organ Protection
LIU Xianbao, ZHANG Chunfang, ZHAN Hong
Department of Anesthesiology, the Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, China
Abstract:
Dexmedetomidine, a new kind of high selective α2 adrenergic receptor agonist, is widely used in calm in severe medicine department, also widely used in perioperative calm and analgesic, and shows obvious advantages in analgesic, inflammatory inhibition, immune regulation and organ protection. This paper summarized the effects in the organ protection aspects for dexmedetomidine according to the literature in recent years.
Key words:  dexmedetomidine  organ protection
扫一扫关注本刊微信